CoChat

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes

Open access
Aleppo, Grazia, Laffel, Lori M, Ahmann, Andrew J, Hirsch, Irl B, Kruger, Davida F, Peters, Anne, Weinstock, Ruth S, Harris, Dennis R · 2017 · Journal of the Endocrine Society
Cited by 123

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

As the accuracy of continuous glucose monitoring (CGM) devices has improved and the benefits are better understood, their use has greatly increased. For patients with diabetes, CGM does more than provide additional data points; it uses trend arrow data to give context to current glucose values. With this level of insight, real-time CGM (rtCGM) has been demonstrated to improve glycemic control without increasing hypoglycemia in patients with type 1 diabetes [1–3] as well as in insulin-treated patients with type 2 diabetes [4, 5]. In December 2016, the US Food and Drug Administration approved the Dexcom G5 Mobile CGM system (Dexcom G5, Dexcom, Inc., San Diego, CA) for nonadjunctive insulin dosing. Aside from the required twice daily calibrations, patients using the Dexcom G5 can now dose insulin without confirmatory fingerstick glucose monitoring in most situations, further improving usability. However, there is sparse guidance for how individuals should act on the trend arrow data. Notably, there are four previously published methods for using trend arrow data to adjust insulin doses [6–9]. However, each method has various limitations in its complexity, utility, and applicability. Our approach focuses on the Dexcom G5 system—the first Food and Drug Administration-approved system for nonadjunctive insulin dosing and the system that we have the most clinical experience using in this manner to date. Our goal is to offer a safe, practical approach for using CGM trend arrow data to adjust insulin dosing. We based this approach on previous algorithms [6,10,11], our clinical experiences as endocrinologists, our personal experiences as people living with diabetes and using CGM, and guidance from other diabetes specialists [8, 12]. Notably, the Klonoff/Kerr formula was published following the development of our guidance and was therefore not used in our comparisons; however, we note the similarities to our own approach and differences in application. Specifically, we aim to address the needs of clinicians treating adult patients living with diabetes requiring intensive insulin therapy who use the Dexcom G5 system. Members of the extended care team, primary care physicians, patients, and caregivers will need tailored information that we plan to develop in the near future. Despite our goal for simplicity, we recognize diabetes management is complex, and treatment decisions require contextual information with trend arrow data being a critical component. Importantly, optimal use of any CGM device relies on understanding the principles, limitations, and caveats to using CGM in the broader context of diabetes management. Lastly, our approach is based upon Dexcom G5 trend arrows and assumes the use of currently available rapid-acting insulin analogs. We recognize that our approach has certain limitations. Currently, there are no clinical trials that have used our suggested approach. We also recognize that other CGM systems, including the recently approved FreeStyle Libre Flash Glucose Monitoring System for nonadjunctive use in adults ages 18 and older, are currently available and provide useful information based on trend arrows. We also expect that additional nonadjunctive CGM systems will likely become available in the future. However, it is important to note that there are no standard conventions for displaying rates of change information in CGM devices and device arrows vary in meaning and display. The suggested approach is a starting point of iterative discussion on how to best use Dexcom G5 trend arrow data. We also hope our approach will be useful when discussing future CGM systems taking into consideration that the transfer, display, and meaning of trend arrow data may be specific for each brand. Recognizing which patients are most likely to benefit from rtCGM and being able to provide adequate education are paramount to the success of rtCGM. For detailed discussions on selecting patients for rtCGM, we recommend the 2016 Endocrine Society practice guideline [13] and American Association of Clinical Endocrinologists consensus statement [14]. Education on using rtCGM is a lengthy topic on its own. However, we highlight the importance of teaching patients the fundamentals of sensor insertion, sensor lag time, calibration, and setting alerts/alarms as well as providing patients with realistic expectations (e.g., rtCGM will not eliminate the need for fingerstick glucose monitoring). For older adults, we stress the importance of ensuring patients can see and hear the alerts and alarms and underscore the value in educating family members and/or caretakers. For all adults, we emphasize that rtCGM relies on an individual’s ability and motivation to use the device on a near daily basis [1, 5]. We offer Table 1 as a list of considerations for recommending rtCGM and Table 2 as a suggested list of education topics [15–17]. Table 3 lists common medications containing acetaminophen, which is an important consideration when using rt

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/js.2017-00388

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 123

Metadata

Authors
Aleppo, G., Laffel, L. M., Ahmann, A. J., Hirsch, I. B., Kruger, D. F., Peters, A., Weinstock, R. S., & Harris, D. R.
Venue
Journal of the Endocrine Society
Published
2017-11-20
Volume
1
Issue
12
Pages
1445-1460
ISSN
2472-1972 (ISSN-L)
OpenAlex
W2769364524
Cited by
123
References
14
FWCI
10.02
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes. https://app.cochat.ai/papers/10.1210/js.2017-00388
The paper
Aleppo, G., Laffel, L. M., Ahmann, A. J., Hirsch, I. B., Kruger, D. F., Peters, A., Weinstock, R. S., & Harris, D. R. (2017). A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes. Journal of the Endocrine Society. https://doi.org/10.1210/js.2017-00388

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.